Update on Fiscal Year 2017

ominious-legislationAs I shared with you earlier this month, President Trump has submitted a supplemental request to Congress for fiscal year (FY) 2017 funding as well as a “budget blueprint” proposal for FY 2018. The administration’s comprehensive FY 2018 budget, that will include specific agency component and program-proposed funding details, is expected to be released later in May. Current FY 2017 funding expires on April 28th, and with this date rapidly approaching, Congress is scheduled to be in recess the weeks of April 10th and 17th, leaving only five legislative days upon their return before funding expires. Congress must either advance a Continuing Resolution (CR) before this date or determine how to proceed on 11 out of 12 remaining appropriations bills, coupled with this new request from the administration for the last five months of the current fiscal year, or face a potential government shutdown.

The administration’s FY 2017 supplemental request recommended that Congress reduce non-defense discretionary agency spending by $18 billion for the remainder of FY 2017. At the time of its release, no specific agencies or programs were proposed or targeted for this significant reduction in current agency spending levels. However, details of the proposed $18 billion in cuts have now come to light — and they include NTEU-represented agencies and programs at EPA, HHS (FDA, HRSA, SAMHSA, ACF), and DOE. At this time, there is significant bipartisan pushback from both congressional chambers against the administration’s FY 2017 request, and these proposed cuts. Additionally, this spending request would violate the established, overall spending caps for FY 2017 as provided under current law under the Budget Control Act of 2011, which is also a concern to significant numbers of lawmakers on both sides of the aisle.

While many in Congress are indicating that they have significant concerns with theseFY 2017 spending recommendations, and expect to act on a CR for the remainder of FY 2017, it is not yet known whether the President would sign such funding legislation if it lacked certain administration priorities. I will keep you updated on the overall funding situation as we approach the April 28th funding deadline.

For more information, please visit our Legislative Action Center.


Author: chapterpresident

I have worked in the FDA since 1990 in a variety of positions. I currently serve as chapter president of NTEU Chapter 254, representing FDA employees in Arkansas, Colorado, Iowa, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, Texas, and Utah.